Get complete Patent Opposition Report for Pfizer Ireland Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Pfizer Ireland Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3269717Aug 9, 2023Polymorphic And Pseudopolymorphic Forms Of Pharmaceutical Compound Nxl1041
EP2357250Oct 6, 2021Production Of Polypeptides2
EP1789571Apr 26, 2017Production Of Polypeptides2